CLDN18 had few mutations in the four cancers, with only a small number of mutations in STAD and CRC, which predominantly consisted of missense mutations and nonsense mutations (Supplementary Figures S2G, H). This evidence concerns the gene CLDN18 and colorectal carcinoma.